Clinical trial
Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With Medium Cut-off Polyarylethersulphone- Polyvinylpirrolidone (Theranova) Membrane
NCT04139525 is registered in ClinicalTrials.gov with Marija Malgaj Vrečko as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With Medium Cut-off Polyarylethersulphone- Polyvinylpirrolidone (Theranova) Membrane
- Lead sponsor
- Marija Malgaj Vrečko
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 15, 2020
- Completion date
- December 31, 2022
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulation, end stage renal disease, haemodialysis